Encision, Inc. Reports Third Quarter Fiscal Year 2017 Results; Sequential Quarterly Revenue Grows 4 Percent Post author:Sam Post published:February 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Alnylam Emerges as Winner in Rare Disease Study Showdown With Ionis November 2, 2017 LAM Therapeutics Scores $58 Million and a New Clinical Program in Cancer March 29, 2017 World's Top 5 Best-Selling Drugs in 2017 December 17, 2017